Acinetobacter Baumannii Case Study

1116 Words3 Pages

A.1. Statement of problem: Acinetobacter baumannii (A. baumannii) is a nosocomial, gram-negative bacterium commonly associated with pneumonia, meningitis, bacteremia, wound and urinary tract infections [1,2,25]. These bacteria are capable of preventing desiccation allowing it to thrive before prolong periods on various wet or dry surfaces. As an opportunistic human pathogen, A. baumannii may colonize a patient without causing any infections or symptoms, especially in tracheostomy sites or open wounds [26]. Historically, A. baumannii infections were clinically treated with different classes of antibiotics such as aminoglycosides, carbapenems, macrolides, and penicillins [2]. However, several studies have recently reported outbreaks of drug-resistant A. baumannii (MRAB) that were unaffected by standard clinical antibiotic treatments [2,1]. Consequently, treating patients infected with A. baumannii has become a clinical challenge and a serious public health concern [2,7].

A.2. …show more content…

B. Background

B.1. Characteristics of Acinetobacter baumannii and Infections they Cause

Acinetobacter baumannii are aerobic and non-fermentative, gram-negative bacteria [6]. This bacterium is an opportunistic pathogen found in soil and water. Also, it is commonly isolated from the hospital environment and hospitalized patients; therefore, it is known to cause nosocomial infections [6,9]. In addition, this bacterium has the ability to adhesion and forming biofilms on abiotic surfaces as well as the ability of secretion of the exopolysaccharide (EPS) a substance that allows the binding of bacterial cells to the surface, and with each other [6,9]. Further more, this bacterium capable of developing a new resistance to antibiotics by several mechanisms such as inhibiting the 30S ribosomal subunit, mutations, or Efflux

More about Acinetobacter Baumannii Case Study

Open Document